319 related articles for article (PubMed ID: 35373500)
1. Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.
Yang M; Wei L
Liver Int; 2022 Aug; 42(9):1981-1990. PubMed ID: 35373500
[TBL] [Abstract][Full Text] [Related]
2. Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B.
Cho H; Chang Y; Lee JH; Cho YY; Nam JY; Lee YB; Lee DH; Cho EJ; Yu SJ; Kim YJ; Lee JM; Yoon JH
J Clin Gastroenterol; 2020 Aug; 54(7):633-641. PubMed ID: 31033805
[TBL] [Abstract][Full Text] [Related]
3. Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.
Yu MW; Lin CL; Liu CJ; Huang YW; Hu JT; Wu WJ; Wu CF
J Formos Med Assoc; 2022 Aug; 121(8):1478-1487. PubMed ID: 34764005
[TBL] [Abstract][Full Text] [Related]
4. Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.
Li J; Yang HI; Yeh ML; Le MH; Le AK; Yeo YH; Dai CY; Barnett S; Zhang JQ; Huang JF; Trinh HN; Wong C; Wong C; Hoang JK; Cheung R; Yu ML; Nguyen MH
J Infect Dis; 2021 Jul; 224(2):294-302. PubMed ID: 33249474
[TBL] [Abstract][Full Text] [Related]
5. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis.
Wong YJ; Nguyen VH; Yang HI; Li J; Le MH; Wu WJ; Han NX; Fong KY; Chen E; Wong C; Rui F; Xu X; Xue Q; Hu XY; Leow WQ; Goh GB; Cheung R; Wong G; Wong VW; Yu MW; Nguyen MH
Clin Mol Hepatol; 2023 Jul; 29(3):705-720. PubMed ID: 37157776
[TBL] [Abstract][Full Text] [Related]
6. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B.
Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liao SH; Hong CM; Liu CH; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
Hepatol Int; 2023 Oct; 17(5):1139-1149. PubMed ID: 37247045
[TBL] [Abstract][Full Text] [Related]
7. NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study.
Yao R; Lu S; Xue R; Wang J; Qiu Y; Chen Y; Liu J; Zhu L; Zhan J; Jiang S; Yin S; Tong X; Ding W; Li J; Zhu C; Huang R; Wu C
Ann Hepatol; 2024; 29(1):101155. PubMed ID: 37742745
[TBL] [Abstract][Full Text] [Related]
8. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of non-alcoholic fatty liver disease in Asia.
Wong SW; Chan WK
Indian J Gastroenterol; 2020 Feb; 39(1):1-8. PubMed ID: 32152903
[TBL] [Abstract][Full Text] [Related]
10. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B.
Mak LY; Hui RW; Fung J; Liu F; Wong DK; Cheung KS; Yuen MF; Seto WK
J Hepatol; 2020 Oct; 73(4):800-806. PubMed ID: 32504663
[TBL] [Abstract][Full Text] [Related]
11. ALT Levels in Treatment-Naive, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A US Nationwide Study.
Chang CY; Kam L; Dang N; Cheung R; Nguyen MH
Dig Dis; 2022; 40(4):497-505. PubMed ID: 34348281
[TBL] [Abstract][Full Text] [Related]
12. [Study on the relationship between nonalcoholic fatty liver disease and hepatocellular carcinoma in patients with prior hepatitis B virus infection].
Chen L; Wang KF; Zhao Z; You QH; Wu YY; Sun J
Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):52-56. PubMed ID: 35152669
[No Abstract] [Full Text] [Related]
13. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma.
Yoon JS; Lee HY; Chung SW; Kim SW; Chang Y; Lee YB; Cho EJ; Lee JH; Yu SJ; Kim H; Yoon JH; Kim YJ
J Gastroenterol Hepatol; 2020 Nov; 35(11):1960-1968. PubMed ID: 32128882
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Hepatic Steatosis on the Natural History of HBV Infection.
Suliman I; Abdelgelil N; Kassamali F; Hassanein TI
Clin Liver Dis; 2019 Aug; 23(3):433-450. PubMed ID: 31266618
[TBL] [Abstract][Full Text] [Related]
16. Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan.
Su HJ; Kao JH; Tseng TC; Yang HC; Su TH; Chen PJ; Liu CJ
J Formos Med Assoc; 2020 Oct; 119(10):1476-1482. PubMed ID: 32499209
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion.
Shi YW; Yang RX; Fan JG
World J Gastroenterol; 2021 Jul; 27(26):3971-3983. PubMed ID: 34326608
[TBL] [Abstract][Full Text] [Related]
18. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
Chu CM
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
[TBL] [Abstract][Full Text] [Related]
19. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.
Yip TC; Wong GL; Chan HL; Tse YK; Lam KL; Lui GC; Wong VW
J Hepatol; 2019 Mar; 70(3):361-370. PubMed ID: 30367899
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta-analysis.
Zhou R; Yang L; Zhang B; Gu Y; Kong T; Zhang W; Sun L; Liu C; Kong N; Li J; Shi J
J Viral Hepat; 2023 Oct; 30(10):793-802. PubMed ID: 37533208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
